Recently visited unit

Optional shares

name	Price (yuan)	Rise and fall
The following are popular stocks

Please check the self selected shares first Sign in

name	Price (yuan)	Rise and fall

Management of self selected shares

^_^ sign out

join remind View in APP

Junshi creature (688180.SH)

Questioning stocks

@change@

@changeP@

@now@

Limit: @ up_limit@

Limit: @ down_limit@

Suspension

@date@ @time@

Temporary suspension

Today:	@open@	Volume:	@volume@	Amplitude:	@swing@
Maximum:	@high@	Turnover:	@amount@	turnover rate:	@turnover@
Minimum:	@low@	Total Market Value:	@fixTotalShare@	P/B ratio:	@pb@
Received yesterday:	@preClose@	Circulation value:	@cvs@	P/E ratio^TTM ：	@pe@
Total share capital:	@zgb@	Circulating shares:	@ltgb@

Information mine:

The browser version is too low to view the multi null inversion

Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox 、 Google

Trend comparison:

market index

Shanghai Stock Exchange Index

Shenzhen Stock Index

CSI 300

compare

Time-sharing

Day K

Week K

Month K

K line

Reinstatement K line

Technical drawings

Trend comparison:

market index

Shanghai Stock Exchange Index

Shenzhen Stock Index

CSI 300

compare

Also concerned:

5th gear disc opening

Live broadcast of famous teachers

Commission ratio -- Abandonment --
Selling ⑤	--	--
Sell ④	--	--
Selling ③	--	--
Sell ②	--	--
Selling ①	--	--
deal	--
Buy ①	--	--
Buy ②	--	--
Buy ③	--	--
Buy ④	--	--
Buy ⑤	--	--
Outer disc -- Inner disc --

In case of a key big order, the main force may**

Quickly use level2 to view details>

Pen by pen

Large order

Price sharing

Time-sharing

time	Price (yuan)	Measurement (hand)	nature

time	Price (yuan)	Measurement (hand)	nature

Transaction price (yuan)	Trading volume (hand)	Proportion (%)

time	Transaction price (yuan)	Trading volume (hand)

Scan code subscription

Investment research report

Questioning stocks

Live broadcast of stock market

Product entry: Sina Finance APP - Stocks - Investment Research Report

Product entrance: Sina Finance APP - stock - free question

money flow

Main compass Indicator description

Main and retail investors' capital flow
	Main buy	Main sales	Purchase by retail investors	Retail sales
Amount (10000 yuan)	@mainIn@	@mainOut@	@retailIn@	@retailOut@
proportion	@mainInP@	@mainOutP@	@retailInP@	@retailOutP@

Loose bill

Small order

Large order

Extra large order

Net inflow of classified funds
	Loose bill	Small order	Large order	Extra large order
Net inflow (10000 yuan)	@r3_r_in@	@r2_r_in@	@r1_r_in@	@r0_r_in@
Proportion in the flow board	@r3_p_svs@	@r2_p_svs@	@r1_p_svs@	@r0_p_svs@
Proportion in turnover rate	@r3_p_turnover@	@r2_p_turnover@	@r1_p_turnover@	@r0_p_turnover@

research report

Company research

Industry research

Big V view

Junshi Biological Stock Exchange

title click reply Final reply

[Junshi Biology and others set up investment funds in Anhui seven hundred and seventy-two zero 05-13 17:47
[Junshi Biology and others invested in the establishment of an equity investment fund in Anhui] seven hundred and sixty-eight zero 05-13 16:05
[Junshi Biology: net loss of 280 million yuan in the first quarter] Junshi one thousand one hundred and thirty zero 04-29 17:26
Junshi Biological: net profit of 280 million yuan in the first quarter eight hundred and twenty-four zero 04-29 17:17
[Junshi Biology: The application for marketing license of Treprizumab was obtained eight hundred and ninety-four zero 04-24 16:43
[Junshi Biological: Terepril Monoclonal Antibody is used in the first line of renal cell carcinoma one thousand one hundred and ninety-three zero 04-07 15:39
On the afternoon of April 9, I went to Junshi Biological to visit and investigate one thousand five hundred and forty-four zero 04-03 18:26
[Junshi Bioboosts 4% Angoreximab Injection New one thousand two hundred and sixty-four zero 04-03 15:20

[Junshi Biological: new indication of Angoreximab injection one thousand five hundred and forty-three zero 04-02 18:01
[Performance report of Junshi Biology: net profit loss in 2023 2 two thousand two hundred and one zero 02-23 18:17
[Junshi Biological: no more than 10% of H shares are planned to be repurchased] two thousand two hundred and thirty-nine zero 02-02 18:40
[Junshi Biology: The application for marketing license of Treprizumab was obtained two thousand four hundred and eighty-seven zero 02-01 17:30
[Junshi Biotech's H-share rose by more than 3%, expected to be net in 2023 two thousand five hundred and fifty-seven zero 01-31 09:27
On January 22, Junshi Biotech now has a block transaction transaction amount two thousand five hundred and thirty-three zero 01-22 17:40
On January 18, Junshi Biology now had a block transaction transaction amount two thousand five hundred and sixty zero 01-18 17:40
Fall like this two hundred and seventy zero 01-17 14:29

Company research

Hot data

Adjacent ranking

Top 10 in the industry

Financial ratios

Adjacent ranking

Top 10 in the industry

Investment rating of research institutions

In the last 60 days Six research reports released Junshi Biological (sh688180) rating, and the comprehensive rating is as follows:

Hot columns

Industry comparison

name	Price (yuan)

expand all Pack All

Investment instruments

Market trend

Distribution

Equity shareholders

Company announcement

financial data

Major events

Company Profile

corporate name:

Shanghai Junshi Biomedical Technology Co., Ltd

Main business:

Development and industrialization of monoclonal antibody drugs and other therapeutic protein drugs, monoclonal antibodies

Telephone: 021-61058800-1153

Fax: 021-61757377

Date of establishment: 2012-12-27

Listing date: 2020-07-15

Legal representative: Xiong Jun

general manager: Zou Jianjun

Registered capital: 985.69 million yuan

Issue price: 55.500 yuan

Latest total share capital: 985689871 shares

Latest outstanding shares: 10000 shares

Segment: Shanghai A-share Shanghai and Shenzhen A-share Shanghai Stock Connect Science and technology innovation board Shanghai Stock Exchange Index Shangzheng Medicine Scientific innovation 50 CSI 500 Innovative medicine Pharmaceutical Biology Biological products Pharmaceutical Biology

Financial summary

2024-03

2023-12

2023-09

2023-06

2023-03

Earnings per share	-RMB 0.2871	-2.3166 yuan	-1.4272 yuan	-1.0119 yuan	-RMB 0.5513
net asset value per share	RMB 6.9657	7.2550 yuan	8.1817 yuan	8.6164 yuan	9.0792 yuan
Net operating cash flow per share	-0.3820 yuan	-2.0341 yuan	-1.6883 yuan	-1.2435 yuan	-0.7307 yuan
Return on net assets	-4.12%	-31.93%	-17.44%	-11.74%	-6.07%
Undistributed profit per share	-9.4787 yuan	-9.1916 yuan	-8.3023 yuan	-7.8869 yuan	-7.4263 yuan
Capital reserve per share	15.6181 yuan	15.6181 yuan	15.6201 yuan	15.6114 yuan	15.6027 yuan

Date of announcement	Allocation scheme

Circulation shareholders

2024-03

2023-12

2023-09

Name of shareholders	Shareholding (%)	Increase or decrease
HKSCC N...	twenty-two point three two eight	Unchanged
Xiong Jun	eight point nine four five	New progress
Shanghai Tanying Investment Co., Ltd	seven point seven nine eight	Unchanged
Suzhou Ruiyuan Shengben	four point four three eight	New progress
Xiong Fengxiang	four point one eight one	New progress
China Merchants Bank Co., Ltd	three point three one four	reduce one's shares in a listed company
Zhou Yuqing	two point two zero eight	New progress
HKSCC has	one point seven one one	Overweight
Industrial and Commercial Bank of China shares	one point six seven six	Overweight
sugus	one point four zero zero	Unchanged

Name of shareholders	Shareholding (%)	Increase or decrease
HKSCC N...	thirty point three two six	Unchanged
Shanghai Tanying Investment Co., Ltd	ten point five nine two	Unchanged
China Merchants Bank Co., Ltd	five point three three seven	Overweight
sugus	one point nine zero one	Overweight
Industrial and Commercial Bank of China shares	one point seven seven two	Overweight
Huang Fei	one point four six four	Unchanged
HKSCC has	one point three three eight	reduce one's shares in a listed company
Wang Zhenhua	one point two one four	reduce one's shares in a listed company
Bank of China shares have	one point one zero seven	reduce one's shares in a listed company
Zhang Jun	zero point nine four six	Unchanged

Name of shareholders	Shareholding (%)	Increase or decrease
HKSCC N...	thirty point three seven seven	Unchanged
Shanghai Tanying Investment Co., Ltd	ten point six one zero	Unchanged
China Merchants Bank Co., Ltd	five point two seven eight	Overweight
HKSCC has	one point eight seven six	Overweight
Industrial and Commercial Bank of China shares	one point seven zero zero	Overweight
Wang Zhenhua	one point five two five	Unchanged
Huang Fei	one point four six six	Unchanged
sugus	one point two three nine	Unchanged
Bank of China shares have	one point one five zero	reduce one's shares in a listed company
Zhang Jun	zero point nine four eight	Unchanged

user name:
Password:
	Record login status for one month
	Sign in Retrieve password Login Help Not yet a member of Sina? New User Registration

Junshi creature (688180.SH)

Investment research report

Live broadcast of stock market

money flow

Company Information

research report

Big V view

Company No

Junshi Biological Stock Exchange

Company research

Hot data

Financial ratios

Investment rating of research institutions

Hot columns

Industry comparison

Investment instruments

Market trend

Company information

Distribution

Equity shareholders

Company announcement

financial data

Major events

Company Profile

Financial summary

Dividend distribution

Circulation shareholders

Shareholding ratio of circulating shareholders